Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations

Pratyaksh K Srivastava1, Aruna D Pradhan2, Nancy R Cook1

  • 1Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Insights

Moderate alcohol consumption is linked to lower levels of cardiac troponin T (hsTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP). These findings suggest potential direct cardiac benefits from regular alcohol intake.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Biomarker Research

Background:

  • Modifiable cardiovascular risk factors like alcohol use, physical activity, diet, and smoking significantly impact myocardial infarction, stroke, and cardiovascular death.
  • Cardiac troponin T (hsTnT) indicates myocyte injury, while B-type natriuretic peptide (NT-proBNP) indicates myocyte stress; both are linked to adverse cardiovascular outcomes.

Purpose of the Study:

  • To investigate the association between lifestyle behaviors, specifically alcohol consumption, and concentrations of hsTnT and NT-proBNP.
  • To determine if modifiable risk factors influence key cardiovascular biomarkers in women without pre-existing cardiovascular disease.

Main Methods:

  • A cohort of 519 women without cardiovascular disease had circulating hsTnT and NT-proBNP levels measured.
  • Logistic regression analysis was employed to assess the relationship between lifestyle behaviors and elevated biomarker levels (hsTnT ≥ 3 ng/l or NT-proBNP in the highest quartile).
  • Findings for NT-proBNP were validated in an independent, larger cohort.

Main Results:

  • The study found that women consuming 1 to 6 drinks per week had significantly lower odds of elevated hsTnT and NT-proBNP levels.
  • Adjusted models showed an odds ratio of 0.58 for hsTnT and 0.55 for NT-proBNP in moderate alcohol consumers compared to non-consumers.
  • The median NT-proBNP was 68.8 ng/l, with 30.8% of the cohort exhibiting hsTnT ≥ 3 ng/l.

Conclusions:

  • Regular, moderate alcohol consumption is associated with lower circulating levels of hsTnT and NT-proBNP.
  • These findings suggest that alcohol may have direct beneficial effects on the myocardium, potentially mediated through these biomarkers.
  • Further research is warranted to explore the mechanistic pathways linking alcohol intake to myocardial health.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
741
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.8K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K